Bionovo, Inc. (BNVI) Tops Q4 Views; Receives Delisting Notice from Nasdaq
Tweet Send to a Friend
Bionovo, Inc. (Nasdaq: BNVI) reported Q4 loss of $0.18, $0.04 better than the analyst estimate of ($0.22). Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
